← Evidence map

ReviewBone marrow transplantation2024

Rituximab for posttransplant lymphoproliferative disorder - therapeutic, preemptive, or prophylactic?

Jan Storek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38001229